Panorama NIPT

Panorama
PANORAMA is a genetic prenatal screening test, done on a blood sample, that detects common chromosomal conditions affecting a baby’s health. Panorama uses SNP*-based technology to give highly accurate results and unique insight into singleton and twin pregnancies.
Panorama can be done as early as the ninth week of gestation. *SNP, single nucleotide polymorphism
- Panorama
- Trisomy 13 (Patau’s syndrome)
- Trisomy 18 (Edwards’ syndrome)
- Trisomy 21 (Down’s syndrome)
- Sex chromosome abnormalities
- Monosomy X (Turner syndrome), Klinefelter syndrome (XXY), Triple X syndrome (XXX), Jacobs syndrome (XYY)
- Triploidy – the presence of an extra set of chromosomes
- Sex of the baby
- Panorama + DiGeorge syndrome
- Panorama basic panel
- 22q11.2 DiGeorge syndrome
- Panorama + 5 microdeletions
- Panorama basic panel
- 22q11
- 1p36
- Cri-du-chat
- Angelman
- Prader-Willi
Why choose the Panorama prenatal test?
It detects conditions that other tests cannot, including molar pregnancy, triploidy and a vanishing twin.
It assesses the risk of Down’s syndrome with an accuracy rate of over 99%.
The only test that distinguishes between the DNA of the pregnant woman and that of the fetus, which helps to avoid false-positive and false-negative results.
The only NIPT that can determine zygosity and the individual fetal fraction in a twin pregnancy.
Its sensitivity for the 22q11.2 microdeletion is over 83%. This common and potentially serious microdeletion affects pregnancies equally, whatever the mother’s age.
It can be done for singleton and twin pregnancies, as well as for pregnancies achieved with donor eggs or surrogacy.
The only prenatal test that can be done as early as the 9th week of gestation.

- Validated in the largest prospective NIPT study
- Technology with unique, clinically proven performance

- Validated in SMART, the largest prospective NIPT study, with over 20,000 participants.
- More than 3 million people in more than 60 countries have chosen Panorama for genetic testing during pregnancy.
- Panorama has been evaluated in more than 25 peer-reviewed publications and in more than 1.3 million pregnancies.
- The lowest fetal fraction that can be analysed is 2.8%, and sex determination is 100% accurate.
- Panorama is performed with a simple blood draw from the pregnant woman and poses no risk to the pregnancy.


It detects common genetic conditions caused by extra or missing chromosomes in the fetus, such as Down’s syndrome, which is caused by extra copies of a particular chromosome, and microdeletions, which result from the loss of a small piece of genetic information. Because Panorama uses unique technology to distinguish between the DNA of the pregnant woman and that of the baby, it is the only NIPT that tests for triploidy and can avoid known sources of error that affect other NIPTs.
The latest ACOG recommendations (American College of Obstetricians and Gynecologists) support NIPT for all pregnancies and:
- Recommend NIPT as an option to be ‘discussed and offered to all patients in early pregnancy, regardless of maternal age or baseline risk’.
- Support cfDNA analysis as ‘the most sensitive and specific screening test for the common fetal aneuploidies’.
- Highlight the unique advantages of SNP-based NIPT, including the detection of triploidy and the unique ability to determine twin zygosity and the individual fetal fraction.

Zygosity detection
Recognised by the International Society for Prenatal Diagnosis (ISPD) as an important element in assessing NIPT results for twins
Individual fetal fraction for dizygotic twins
An important metric needed to interpret the reliability of NIPT results; ACOG recognises that without this measurement, an aneuploidy could go undetected if the affected twin has a low fetal fraction
Fetal sex determination
Panorama has made zero errors in determining the baby’s sex – in both singleton and twin pregnancies
Panorama identified monozygotic twins with >99% sensitivity and specificity in a validation study.
Although chorionicity can be reliably detected in early pregnancy, studies have shown that up to 19% of monochorionic pregnancies are wrongly classified as dichorionic. Panorama allows doctors to align their ultrasound findings with an early and accurate determination of zygosity.
Identifying a monozygotic twin pregnancy with Panorama can prompt earlier, targeted ultrasound assessments of chorionicity and related complications such as twin-to-twin transfusion syndrome (TTTS).
The management of a twin pregnancy is strongly influenced by chorionicity; determining zygosity with the Panorama prenatal test can therefore help doctors decide on the appropriate plan for managing the pregnancy

Note
Panorama is a screening test, which means that it does not give a definitive diagnosis. A high-risk result means that there is a higher chance of a specific genetic condition in the fetus, but all medical decisions should be made after talking to a gynaecologist about further diagnostic testing during pregnancy, such as chorionic villus sampling (CVS) or amniocentesis, or testing the baby after birth.
For more information, call: 066 821 6197